Healthcare - Biotechnology - NASDAQ - US
$ 3.85
-1.79 %
$ 414 M
Market Cap
-3.35
P/E
BALANCE SHEET
403 M
ASSETS
149 M
LIABILITIES
253 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Tango Therapeutics, Inc.
| Current Assets | 347 M |
| Cash & Short-Term Investments | 337 M |
| Receivables | 0 |
| Other Current Assets | 9.65 M |
| Non-Current Assets | 56 M |
| Long-Term Investments | 0 |
| PP&E | 53.4 M |
| Other Non-Current Assets | 2.61 M |
| Current Liabilities | 45.9 M |
| Accounts Payable | 2.78 M |
| Short-Term Debt | 2.08 M |
| Other Current Liabilities | 41.1 M |
| Non-Current Liabilities | 104 M |
| Long-Term Debt | 36.8 M |
| Other Non-Current Liabilities | 66.7 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash & Cash Equivalents | 66.4 | 60.0 | 142.7 | 28.4 | 22.9 |
| Short Term Investments | 270.5 | 306.2 | 342.5 | 161.9 | 17.5 |
| Receivables | 0 | 2.0 | 2.0 | 2.0 | 0 |
| Inventory | 0 | 0.6 | 0.6 | 0 | 0 |
| Other Current Assets | 9.7 | 13.7 | 5.1 | 0.2 | 1.2 |
| Total Current Assets | 346.5 | 375.3 | 492.3 | 193.6 | 41.7 |
| PP&E | 53.4 | 57.8 | 6.1 | 11.3 | 11.8 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 3.4 | 1.7 | 2.3 | 0 |
| Other Long Term Assets | 2.6 | 3.4 | 19 K | 38 K | 2.3 |
| Other Assets | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 402.6 | 436.5 | 500.2 | 207.3 | 55.8 |
| LIABILITIES | |||||
| Accounts Payable | 2.8 | 4.5 | 3.2 | 1.8 | 0.7 |
| Short Term Debt | 2.1 | 3.5 | 3.0 | 1.0 | 0.7 |
| Other Current Liabilities | 15.4 | 15.7 | 8.4 | 6.1 | 24.5 |
| Total Current Liabilities | 45.9 | 55.5 | 40.7 | 40.9 | 25.9 |
| Long Term Debt | 36.8 | 39.4 | 0 | 6.9 | 7.9 |
| Deferred Tax Income | 0 | 15.0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 0 | 5 K | 14.1 |
| Total Liabilities | 149.5 | 187.0 | 155.4 | 168.7 | 47.9 |
| EQUITY | |||||
| Common Stock | 0.1 | 88 K | 88 K | 40 K | 13 K |
| Retained Earnings | (371.3) | (269.5) | (161.3) | (103.1) | (51.1) |
| Other Accumulative Comprehensive Income/Loss | 0.2 | (3.7) | (0.8) | 17 K | 10 K |
| Total Equity | 253.1 | 249.5 | 344.7 | 38.6 | 7.9 |
| Total Liabilities and Equity | 402.6 | 436.5 | 500.2 | 207.3 | 55.8 |
| SHARES OUTSTANDING | |||||
| Common Shares Outstanding | 94.6 | 87.8 | 62.1 | 31.9 | 9.0 |